GREENWICH LIFESCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.34 USD | +2.50% |
|
+9.30% | +36.31% |
Chart calendar Greenwich LifeSciences, Inc.
14d2d369.Z2kPHyOmovKvq_Hf1fX8GFYAXoodI3QHMzr1PTljiyM.Ay9_U3Dp1Mvpw7WHm5CSfQJjK89-Zx10AEKlX1USs000Xmlrd9bEypb0ng~18356a9ad2eba8d8de767a44254e175c
Upcoming events on Greenwich LifeSciences, Inc.
No events available
Past events on Greenwich LifeSciences, Inc.
| 15/12/2023 14:00 | Annual General Meeting |
| 08/12/2022 | Annual General Meeting |
| 12/06/2022 | BIO International Convention |
| 07/06/2022 | Jefferies Healthcare Conference |
| 02/06/2022 | American Society of Clinical Oncology Meeting - Abstract Number: TPS1110 |
| 02/06/2022 | American Society of Clinical Oncology Meeting - Abstract Number: e12519 |
| 02/06/2022 | American Society of Clinical Oncology Meeting - Abstract Number: LBA550 |
| 22/05/2022 | H.C. Wainwright Global Life Sciences Investment Conference |
| 07/04/2022 | American Association of Cancer Research Meeting |
| 27/03/2022 | BIO Europe Spring |
| 14/02/2022 19:30 | Bio CEO & Investor Conference |
| 15/12/2021 14:00 | Annual General Meeting |
| 06/12/2021 | San Antonio Breast Cancer Symposium |
| 15/11/2021 | Jefferies London Healthcare Conference |
| 29/09/2021 19:00 | Cantor Fitzgerald Global Healthcare Conference |
| 29/09/2021 14:30 | Benzinga Healthcare Small Cap Conference |
| 12/09/2021 | H.C. Wainwright Global Investment Conference |
| 07/09/2021 | Citigroup BioPharma Conference |
| 09/04/2021 | American Association for Cancer Research Conference |
| 24/03/2021 | Benzinga Biotech Small-Cap Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -1,86 -13,0 85.66% | -4,60 -3,17 -45% | -8,04 -7,50 -7.26% | -9,33 -9,04 -3.16% | -10,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -4,57 -3,16 -44.64% | -7,83 -7,40 -5.69% | -8,89 -8,70 -2.26% | -10,2 |
|
Net income Million USD | Released Forecast Spread | -3,43 | -1,86 -13,0 85.67% | -4,57 -3,16 -44.64% | -7,83 -7,39 -5.96% | -8,89 -8,70 -2.26% | -10,2 |
|
EPS USD | Released Forecast Spread | -1,52 | -0,20 -1,02 80.39% | -0,35 -0,24 -45.83% | -0,61 -0,57 -7.02% | -0,69 -0,68 -1.47% | -0,76 |
| Announcement Date | 29/05/20 | 31/03/21 | 21/03/22 | 31/03/23 | 15/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,38 -0,95 -150.23% | -1,99 -2,45 18.81% | -0,77 -2,45 68.44% | -2,38 -2,45 2.73% | -2,89 -2,35 -23.18% | -2,24 -3,00 25.3% | -1,75 -3,00 41.74% | -2,50 -3,00 16.57% | -2,84 -2,55 -11.22% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,36 -0,95 -148.5% | -1,97 -2,45 19.61% | -0,75 -2,45 69.55% | -2,32 -2,45 5.35% | -2,79 -2,35 -18.75% | -2,12 -3,00 29.17% | -1,63 -3,00 45.72% | -2,39 -3,00 20.27% | -2,75 -2,55 -7.72% | ||||
|
Net income Million USD | Released Forecast Spread | -2,36 -0,95 -148.5% | -1,97 -2,45 19.61% | -0,75 -2,45 69.55% | -2,32 -2,45 5.35% | -2,79 -2,35 -18.75% | -2,12 -3,00 29.17% | -1,63 -3,00 45.72% | -2,39 -3,00 20.27% | -2,75 -2,55 -7.72% | ||||
|
EPS USD | Released Forecast Spread | -0,18 -0,07 -157.14% | -0,15 -0,19 21.05% | -0,06 -0,19 68.42% | -0,18 -0,19 5.26% | -0,22 -0,18 -22.22% | -0,17 -0,23 26.09% | -0,13 -0,23 43.48% | -0,19 -0,22 13.64% | -0,21 -0,20 -5% | -0,20 | -0,20 | -0,19 | -0,18 |
| Announcement Date | 21/03/22 | 20/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 22/05/23 | 21/08/23 | 19/10/23 | 15/04/24 | - | - | - | - |
| 06/05/2024 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
| 07/05/2024 12:30 | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 08/05/2024 12:55 | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for Greenwich LifeSciences, Inc.
| 02/05/2024 21:05 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 12:50 | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 30/04/2024 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 29/04/2024 22:53 | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 28/04/2024 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLSI Stock
- Calendar Greenwich LifeSciences, Inc.
